Literature DB >> 6334780

25-Hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human cerebrospinal fluid.

S Balabanova, H P Richter, G Antoniadis, J Homoki, N Kremmer, J Hanle, W M Teller.   

Abstract

Samples of CSF and plasma were obtained simultaneously from 46 adult patients who had no endocrine disorders and were undergoing routine diagnostic lumbar puncture because of suspected or proved prolapse of a disc. Concentrations of 25-OHD, 24,25(OH)2D and 1,25(OH)2D were measured. The samples were purified by column chromatography and fractionated by HPLC. In the appropriate fractions the vitamin D metabolites were measured by PBA, and cytoreceptor assay. The results were as follows (median, range in brackets): 25-OHD in CSF 8.3 ng/ml (2.0-24.8), in plasma 14.5 ng/ml (7.0-36.0). 24,25(OH)2D in CSF 1.8 ng/ml (0.3-4.6) and 2.5 ng/ml (0.4-4.7) in plasma. 1.25(OH)2 D in CSF 25.0 pg/ml (2.2-39.0) and 31.0 pg/ml (10.1-55.0) in plasma. The correlations between plasma and CSF concentrations were as follows: 25-OHD r = 0.479 (P less than 0.001); 24,25(OH)2D r = 0.815 (P less than 0.001) and for 1.25(OH)2D r = 0.497 (P less than 0.001). Our findings showed vitamin D metabolites to be present in human CSF.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334780     DOI: 10.1007/bf01711378

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  27 in total

1.  Intoxication with vitamin D.

Authors:  J E HOWARD; R J MEYER
Journal:  J Clin Endocrinol Metab       Date:  1948-11       Impact factor: 5.958

2.  Some effects of dehydroascorbic acid on the central nervous system.

Authors:  J W PATTERSON; D W MASTIN
Journal:  Am J Physiol       Date:  1951-10

3.  Ascorbic acid homeostasis in the central nervous system.

Authors:  R Spector; A V Lorenzo
Journal:  Am J Physiol       Date:  1973-10

4.  Immunohistochemical mapping of vitamin D-dependent calcium-binding protein in brain.

Authors:  S S Jande; L Maler; D E Lawson
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

5.  Specific neurons in chick central nervous system stain with an antibody against chick intestinal vitamin D-dependent calcium-binding protein.

Authors:  J Roth; D Baetens; A W Norman; L M Garcia-Segura
Journal:  Brain Res       Date:  1981-10-19       Impact factor: 3.252

6.  The cytoreceptor assay for 1,25-dihydroxyvitamin D and its application to clinical studies.

Authors:  S C Manolagas; F L Culler; J E Howard; A S Brickman; L J Deftos
Journal:  J Clin Endocrinol Metab       Date:  1983-04       Impact factor: 5.958

7.  Thiamine transport in the central nervous system.

Authors:  R Spector
Journal:  Am J Physiol       Date:  1976-04

8.  [Observations in vitamin D and dihydrotachysterol poisoning].

Authors:  R Ziegler; H Minne; F Raue; G Paar; G Delling
Journal:  Dtsch Med Wochenschr       Date:  1975-02-28       Impact factor: 0.628

9.  Chick brain calcium binding protein: response to cholecalciferol and some developmental aspects.

Authors:  A N Taylor
Journal:  J Nutr       Date:  1977-03       Impact factor: 4.798

10.  Localization of immunoreactive vitamin D-dependent calcium binding protein in chick nephron.

Authors:  S Christakos; M G Brunette; A W Norman
Journal:  Endocrinology       Date:  1981-07       Impact factor: 4.736

View more
  19 in total

1.  Expression of cholinergic, insulin, vitamin D receptors and GLUT 3 in the brainstem of streptozotocin induced diabetic rats: effect of treatment with vitamin D₃.

Authors:  T Peeyush Kumar; Jes Paul; Sherin Antony; C S Paulose
Journal:  Neurochem Res       Date:  2011-06-26       Impact factor: 3.996

2.  Vitamin D target systems in the brain of the green lizard Anolis carolinensis.

Authors:  H J Bidmon; W E Stumpf
Journal:  Anat Embryol (Berl)       Date:  1996-02

3.  Role of 1,25-dihydroxyvitamin D3 and extracellular calcium in the regulation of proliferation in cultured SH-SY5Y human neuroblastoma cells.

Authors:  A Celli; C Treves; P Nassi; M Stio
Journal:  Neurochem Res       Date:  1999-05       Impact factor: 3.996

Review 4.  Possibility of a new anti-alzheimer's disease pharmaceutical composition combining memantine and vitamin D.

Authors:  Cédric Annweiler; Olivier Beauchet
Journal:  Drugs Aging       Date:  2012-02-01       Impact factor: 3.923

Review 5.  Vitamin D and neurocognitive dysfunction: preventing "D"ecline?

Authors:  Jennifer S Buell; Bess Dawson-Hughes
Journal:  Mol Aspects Med       Date:  2008-05-13

6.  Effect of Early High-Dose Vitamin D3 Repletion on Cognitive Outcomes in Critically Ill Adults.

Authors:  Jin H Han; Adit A Ginde; Samuel M Brown; Adrienne Baughman; Erin M Collar; E Wesley Ely; Michelle N Gong; Aluko A Hope; Peter C Hou; Catherine L Hough; Theodore J Iwashyna; James C Jackson; Akram Khan; Onur M Orun; Mayur B Patel; Rameela Raman; Todd W Rice; Nancy Ringwood; Matthew W Semler; Nathan I Shapiro; Daniel S Talmor; Wesley H Self
Journal:  Chest       Date:  2021-04-02       Impact factor: 10.262

Review 7.  Sample preparation techniques for extraction of vitamin D metabolites from non-conventional biological sample matrices prior to LC-MS/MS analysis.

Authors:  Anastasia Alexandridou; Dietrich A Volmer
Journal:  Anal Bioanal Chem       Date:  2022-05-02       Impact factor: 4.478

8.  Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.

Authors:  Per Johansson; Erik G Almqvist; Jan-Ove Johansson; Niklas Mattsson; Ulf Andreasson; Oskar Hansson; Anders Wallin; Kaj Blennow; Henrik Zetterberg; Johan Svensson
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

Review 9.  Vitamin D: Current Challenges between the Laboratory and Clinical Practice.

Authors:  Ludmila Máčová; Marie Bičíková
Journal:  Nutrients       Date:  2021-05-21       Impact factor: 5.717

Review 10.  Vitamin D in the time of the coronavirus (COVID-19) pandemic - a clinical review from a public health and public mental health perspective.

Authors:  Ursula Werneke; Fiona Gaughran; David M Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.